Washington legislation · 2025-26 Regular Session
Washington SB6183: HIV antiviral drug coverage
Status: Signed into law, March 14, 2026
Concerning coverage for HIV antiviral drugs.
What the bill says
An act Relating to coverage for HIV antiviral drugs; reenacting and amending RCW 41.05.017; and adding a new section to chapter 48.43 RCW. NEW SECTION.
From the enrolled text:
AN ACT Relating to coverage for HIV antiviral drugs; reenacting and amending RCW 41.05.017; and adding a new section to chapter 48.43 RCW. NEW SECTION. Sec. 1. A new section is added to chapter 48.43 RCW to read as follows: (1) For health plans issued or renewed on or after January 1, 2027, except as provided in subsection (2) of this section, a health carrier shall provide coverage for all federal food and drug administration approved HIV antiviral drugs without prior authorization, step therapy, or any other utilization management protocols. (2) If the United States food and drug administration has approved one or more therapeutic equivalents of a drug, device, or product for the prevention or treatment of HIV, this section does not require a health plan to cover all of the therapeutically equivalent versions without prior authorization, step therapy, or any other utilization management protocols, if at least one therapeutically equivalent version is covered without prior authorization, step therapy, or any other utilization management protocols. Sec. 2. RCW 41.05.017 and 2025 c 389 s 3 and 2025 c 171 s 2 are each reenacted and amended to read as follows: Each health plan that provides medical insurance offered under this chapter, including plans created by insuring entities, plans not subject to the provisions of Title 48 RCW, and plans …
Sponsors
- Marko Liias (D) · primary sponsor
- Paul Harris (R)
- Jessica Bateman (D)
- Annette Cleveland (D)
- Wilson, Claire (D, 30)
- Manka Dhingra (D)
- Robert Hasegawa (D)
- T'wina Nobles (D)
- Jamie Pedersen (D)
- Rebecca Saldaña (D)
- Derek Stanford (D)
- Yasmin Trudeau (D)
Latest actions
- : Effective date 6/11/2026.
- : Chapter 48, 2026 Laws.
- : Governor signed.
- : Delivered to Governor.
- : Speaker signed.
- : President signed.
- : Third reading, passed; yeas, 93; nays, 1; absent, 0; excused, 4.
- : Rules suspended. Placed on Third Reading.
- : Rules Committee relieved of further consideration. Placed on second reading.
- : Referred to Rules 2 Review.
Votes
- 3rd Reading & Final Passage (March 3, 2026): 93 yea, 1 nay, passed
- House Committee on Health Care & Wellness: Do pass (February 25, 2026): 18 yea, 0 nay, passed
- 3rd Reading & Final Passage (February 10, 2026): 48 yea, 0 nay, passed
- Senate Committee on Health & Long-Term Care: That Substitute Senate Bill No. 6183 be substituted therefor, and the substitute bill do pass (January 27, 2026): 10 yea, 0 nay, passed
Subjects: HEALTH INSURANCE
Common questions
- What is SB6183?
- SB6183 is a bill in the Washington Legislature (2025-26 Regular Session): HIV antiviral drug coverage.
- What does SB6183 do?
- In its own words: An act Relating to coverage for HIV antiviral drugs; reenacting and amending RCW 41.05.017; and adding a new section to chapter 48.43 RCW. NEW SECTION.
- What is the status of SB6183?
- Signed into law as of March 14, 2026. Latest action: Effective date 6/11/2026. (March 14, 2026).
- Who sponsored SB6183?
- Marko Liias (D), with 11 co-sponsors.
- Where is the official record for SB6183?
- On the Washington Legislature website: https://app.leg.wa.gov/billsummary?BillNumber=6183&Year=2025
Source: official Washington record. Tracked by Delilah, AI for legislation across all 50 states and Congress.